Key result
Indigenous status in AMI is linked to less thrombolytic therapy, driven by longer presentation delays.
Why the study?
Are there differences in presentation delays and management of acute myocardial infarction between Indigenous and non-Indigenous patients?
Observational (n=122)
Yes
Are there differences in presentation delays and management of acute myocardial infarction between Indigenous and non-Indigenous patients?
Indigenous patients with acute myocardial infarction experience significantly longer delays to hospital presentation, reducing their eligibility for time-sensitive therapies like thrombolysis.
Answers are grounded in this paper and cite their sources.
Longer presentation delays may limit thrombolysis eligibility for Indigenous AMI patients; leaves open whether targeted interventions can reduce disparities.
OBJECTIVES: To investigate differences in presentation and management of Indigenous and non-Indigenous patients hospitalised with acute myocardial infarction (AMI). DESIGN: Retrospective review of hospital medical records. PARTICIPANTS AND SETTING: 122 patients with definite or possible AMI admitted to hospitals in the Top End of the Northern Territory (NT) in 1996. MAIN OUTCOME MEASURES: Percentage receiving thrombolytic therapy; delays from symptom onset to primary and emergency department presentations, first and diagnostic electrocardiograms, thrombolytic therapy and aspirin; drugs prescribed during hospitalisation. RESULTS: Thrombolytic therapy was given to 12/41 Indigenous patients (29%) and 38/81 non-Indigenous patients (47%) (P = 0.06). Presentation delay over 12 hours was the reason for not giving thrombolytic therapy for 14/29 Indigenous patients (48%) and 8/43 non-Indigenous patients (19%) (P < 0.01). Median delay times were longer for Indigenous patients for all six categories of delay, although the difference was significant only for delay to emergency department presentation (10:00 versus 3:26 hours; P < 0.01) and to diagnostic electrocardiogram (8:10 versus 3:50 hours; P < 0.01). Delays were also longer for patients from rural compared with urban areas. Once diagnosed, Indigenous patients were as likely as non-Indigenous patients to receive aspirin (93% versus 96%) and beta-blockers (70% versus 69%) and more likely to receive angiotensin-converting enzyme inhibitors (60% versus 40%; P = 0.03). CONCLUSIONS: Delays in presentation affect Indigenous people living in rural and urban areas as well as non-Indigenous people living in rural areas. Concerted efforts are needed to improve health service access in rural areas and to encourage Indigenous people with persistent chest pain to present earlier.
No takes yet. Share an insight, caveat, or question.
Ong et al. (2000) conducted an observational in acute myocardial infarction (n=122). Indigenous status vs. Non-Indigenous status was evaluated on Percentage receiving thrombolytic therapy (p=0.06). Indigenous patients hospitalized with AMI received thrombolytic therapy less frequently than non-Indigenous patients, primarily due to longer delays to hospital presentation.
Synapse has enriched 10 related papers. Consider them for comparative context: